These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32015422)
1. Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting. Kim J; Park J; Lee JH; Min JJ; Lee SH; Lee YT; Kim WS; Song S; Yeo JH; Cho H Sci Rep; 2020 Feb; 10(1):1716. PubMed ID: 32015422 [TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea. Lee J; Lee S Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. Manning MW; Cooter M; Mathew J; Alexander J; Peterson E; Ferguson TB; Lopes R; Podgoreanu M Ann Thorac Surg; 2017 Jul; 104(1):98-105. PubMed ID: 28131423 [TBL] [Abstract][Full Text] [Related]
4. Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study. Barry AR; Helisaz H; Safari A; Loewen P J Am Heart Assoc; 2024 Jun; 13(12):e035215. PubMed ID: 38842283 [TBL] [Abstract][Full Text] [Related]
5. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention. Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH; Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681 [TBL] [Abstract][Full Text] [Related]
7. Which patients should be on renin-angiotensin system blockers after coronary surgery? Alassar A; Bazerbashi S; Easto R; Unsworth-White J Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):667-72. PubMed ID: 24997188 [TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting. Johnston K; Stephens S Ann Pharmacother; 2012 Sep; 46(9):1239-44. PubMed ID: 22947592 [TBL] [Abstract][Full Text] [Related]
9. Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program. Bainey KR; Armstrong PW; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Zhao X; Schwamm LH; Bhatt DL Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):227-35. PubMed ID: 24569634 [TBL] [Abstract][Full Text] [Related]
10. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used? Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L Nephron; 2019; 143(2):100-107. PubMed ID: 31203280 [TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study. Shih CJ; Chu H; Ou SM; Chen YT Int J Cardiol; 2015 Nov; 199():283-9. PubMed ID: 26218587 [TBL] [Abstract][Full Text] [Related]
12. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Armstrong EJ; Chen DC; Singh GD; Amsterdam EA; Laird JR Vasc Med; 2015 Jun; 20(3):237-44. PubMed ID: 25835349 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a nationwide study. Shih CJ; Chen HT; Chao PW; Kuo SC; Li SY; Yang CY; Tarng DC; Ou SM; Chen YT J Hypertens; 2016 Mar; 34(3):567-74; discussion 575. PubMed ID: 26703918 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease. Juneja A; Zia S; Abeysekara A; Shams S; Singh K; Schor J; Deitch J Vascul Pharmacol; 2020 Aug; 131():106764. PubMed ID: 32629143 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251 [TBL] [Abstract][Full Text] [Related]
17. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan. Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185 [TBL] [Abstract][Full Text] [Related]
18. Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention. Ann SH; Strauss MH; Park GM; Han S; Yang Y; Kim YG; Won KB; Kim SJ; Lee SG; Cho YR; Kim DW; Park MW; Her SH; Lee SW Int J Cardiol; 2020 May; 306():35-41. PubMed ID: 31727411 [TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis. Wu CK; Yang YH; Juang JJ; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY Medicine (Baltimore); 2015 Jan; 94(3):e424. PubMed ID: 25621694 [TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI; Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]